Q3 2025 Earnings Call November 13, 2025 2:00 AM ESTCompany ParticipantsMichael Szucs - Chief Executive OfficerTrina Asuncion ...
Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback